|
KR20200143785A
|
|
A sustained-release tablet comprising a potassium citrate composition
|
|
KR20200113116A
|
|
A film-coated tablet comprising deferasirox
|
|
KR20190142620A
|
|
Oral solid formulation composition for purgative comprising sodium sulfate anhydrous, potassium sulfate, magnesium sulfate anhydrous and simethicone
|
|
KR20190110771A
|
|
Compact dispersible tablet comprising deferacirox
|
|
KR20190041233A
|
|
Colonic purgative composition comprising sulfate salts
|
|
KR20190004134A
|
|
Pharmaceutical composition and method of fabricating the same
|
|
KR20180091572A
|
|
Colonic purgative composition for oral administration
|
|
KR101524473B1
|
|
Injectable composition
|
|
KR101486534B1
|
|
Oral preparation and preparation method of the same
|
|
CA2942878A1
|
|
Pharmaceutical liquid composition comprising sodium picosulfate, magnesium oxide, citric acid and malic acid
|
|
KR20150069293A
|
|
Pharmaceutical composition and method of fabricating the same
|
